arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

GoodRx Holdings, Inc.

GDRX
$3.67 ▼ -0.06 (-1.61%) at close
Technology ·Services-Computer Processing & Data Preparation ·USServices-Computer Processing & Data Preparation
31 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
60
Health
Fair
Neutral
auto_awesome

Analytical Summary

GoodRx Holdings, Inc. shows mixed fundamentals. Consider comparing against peers in the Technology sector before making investment decisions.

Market Cap $1.2B
Dividend Yield
Revenue Growth -4.4%
Op. Margin 7.2%
ROIC 0.3%
FCF / Share $0.03
Trailing P/E
Price / Book 2.0x
FCF Yield 0.9%
Debt / Equity 0.78
info Valuation on last close. End-of-day price, Aug 7, 2026.

31-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$194.01M
↓ -4.4%
Net Income Profit after all expenses
$1.17M
↓ -89.4%
Operating Margin Operating profit as % of sales
7.2%
↓ -38.0% 59th
FCF / Share Free cash flow per share
$0.03
↑ +28.5%
Long-Term Debt Long-term obligations
$482.42M
↓ -2.5%

Health Breakdown

Profitability
62
Returns
54
Financial Health
48
Cash Quality
96

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 31 quarters